Find out more

EMCDDA publications

2017
Cannabis legislation in Europe: an overview.
Country Drug Reports 2017.
Drug trafficking penalties across the European Union: a survey of expert opinion, Technical reports.
2016
Cocaine trafficking to Europe, Perspectives on Drugs.
Changes in Europe’s cannabis resin market, Perspectives on Drugs.
Internet and drug markets, Insights.
2015
Opioid trafficking routes from Asia to Europe, Perspectives on Drugs.
New psychoactive substances in Europe. An update from the EU Early Warning System, Technical reports.
The internet and drug markets, Technical reports.
2014
New developments in Europe’s cannabis markets, Perspectives on Drugs.
2013
Drug supply reduction and internal security, EMCDDA Papers.
Legal approaches to controlling new psychoactive substances, Perspectives on Drugs.
Models for the legal supply of cannabis: recent developments, Perspectives on Drugs.
Synthetic cannabinoids in Europe, Perspectives on Drugs.
Synthetic drug production in Europe, Perspectives on Drugs.
2012
Cannabis production and markets in Europe, Insights.

EMCDDA and Europol joint publications

2017
EMCDDA–Europol Joint Report on a new psychoactive substance: acryloylfentanyl, Joint Reports.
2016
EU Drug Markets Report: In-depth Analysis.
EU Drug Markets Report: Strategic Overview.
EMCDDA–Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA.
EMCDDA–Europol Joint Report on MDMB-CHMICA, Joint Reports.
EMCDDA–Europol Joint Report on acetylfentanyl, Joint Reports.
2015
EMCDDA–Europol Joint Report on a new psychoactive substance: α-PVP, Joint Reports.
2013
Amphetamine: a European Union perspective in the global context.

EMCDDA and Eurojust joint publications

2016
New psychoactive substances in Europe: legislation and prosecution - current challenges and solutions.

All publications are available at https://www.euda.europa.eu/publications

Top